Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698399 · ClinicalTrials.gov registry record
Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT00698399: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00698399 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698399 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-02-02 |
What the finished NCT00698399 record still lists
NCT00698399 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00698399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00698399 about?
NCT00698399 is a clinical study titled "Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients". This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.
What is the current status of trial NCT00698399?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-03. Estimated completion is 2010-02-02.
Who is sponsoring clinical trial NCT00698399?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia